Thomas et al. retrospectively investigated 10 patients with microscopic colitis (six with collagenous colitis and four with lymphocytic colitis) who received PD-1 or programmed cell death ligand 1 inhibitors [21]. This evidence concerns the gene PDCD1 and microscopic colitis.